PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2010 | 5 | 1 | 75-82
Article title

Manifestation peculiarities of idiopathic chronic eosinophilic pneumonia

Content
Title variants
Languages of publication
EN
Abstracts
EN
Chronic eosinophilic pneumonia is a rare interstitial lung disorder, which causes diagnostic difficulties. Often the disease is diagnosed correctly after several weeks or months following initial presentation. The aim of the study was to prospectively evaluate peculiarities of manifestation of idiopathic chronic eosinophilic pneumonia (ICEP), which may allow to improving early diagnosis. Twenty patients with ICEP were involved in this investigation. The cases of acute eosinophilic pneumonia and cases of chronic eosinophilic pneumonia of known origin were excluded. To define archetypal signs of the idiopathic chronic eosinophilic pneumonia, 3 comparable groups were selected. They were the group of 50 patients with community-acquired pneumonia (COP); the group of 21 asthmatic patients with COP, and the cluster of 10 patients with morphologically confirmed cryptogenic organizing pneumonia (OP). Clinical and radiological manifestation of ICEP was similar to COP and cryptogenic OP manifestation. We have found that chest pain; fine rales and pleurisy were unrepresentative for ICEP. However, blood eosinophilia was typical sign of ICEP and wheezing was a frequent observation. Usually ICEP patients had relative mild clinical symptoms and moderate increased C reactive protein (CRP) level even in cases of multiple pulmonary infiltrates. In conclusion, in cases of not typical pneumonia course, i.e. non-resolving or recurrent pulmonary infiltrates; relative mild clinical symptoms and moderate increased CRP level with multiple pulmonary infiltrates; blood eosinophilia and/or signs of airway obstruction eosinophilic pneumonia should be suspected and bronchoalveolar lavage and/or bronchoscopic lung biopsy performed.
Publisher
Journal
Year
Volume
5
Issue
1
Pages
75-82
Physical description
Dates
published
1 - 2 - 2010
online
29 - 1 - 2010
References
  • [1] Crofton J.W., Livingstone J.L., Oswald N.C., Roberts A.T.M., Pulmonary eosinophilia, Thorax, 1952, 7, 1–35 http://dx.doi.org/10.1136/thx.7.1.1[Crossref]
  • [2] Ogawa H., Fujimura M., Matsuda T., Nakamura H., Kumabashiri I., Kitagawa S. Transient wheeze. Eosinophilic bronchobronchiolitis in acute eosinophilic pneumonia, Chest, 1993, 104, 493–6 http://dx.doi.org/10.1378/chest.104.2.493[Crossref]
  • [3] Boomars K.A., van Velzen-Blad H., Mulder P.G., Koenderman L., Lammers J.W., van den Bosch J.M.M., Eosinophil cationic protein and immunoglobulin levels in bronchoalveolar lavage fluid obtained from patients with chronic eosinophilic pneumonia, Eur. Respir. J, 1996, 9, 2488–93 http://dx.doi.org/10.1183/09031936.96.09122488[Crossref]
  • [4] Trawick D., Kotch A., Matthay R., Homer R.J., Eosinophilic pneumonia as a presentation of occult chronic granulomatous disease, Eur. Respir. J., 1997, 10, 2166–70 http://dx.doi.org/10.1183/09031936.97.10092166[Crossref]
  • [5] Shorr A.F., Scoville S.L., Cersovsky S.B., Shanks G.D., Ockenhouse C.F., Smoak B.L., et al., Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq, J. A. M. A., 2004, 292, 2997–3005 http://dx.doi.org/10.1001/jama.292.24.2997[Crossref]
  • [6] Souza C.A., Müller N.L., Johkoh T., Akira M. Drug-induced eosinophilic pneumonia: high-resolution CT findings in 14 patients, A. J. R., 2006, 186, 368–73
  • [7] Espeleta V.J., Moore W.H., Kane P.B., Baram D., Eosinophilic pneumonia due to duloxetine, Chest, 2007, 131, 901–3 http://dx.doi.org/10.1378/chest.06-1659[Crossref]
  • [8] Carrington C.B., Addington W.W., Goff A.M., Madoff I.M., Marks A., Schwaber J.R., et al., Chronic eosinophilic pneumonia, N. Engl. J. Med., 1969, 280, 787–98
  • [9] Allen J.N., Pacht E.R., Gadek J.E., Davis W.B., Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure, N. Engl. J. Med., 1989, 321, 569–74
  • [10] Fujimura M., Yasui M., Shinagawa S., Nomura M., Matsuda T., Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: acute, chronic and drug-induced eosinophilic pneumonia, Respir. Med., 1998, 92, 743–9 http://dx.doi.org/10.1016/S0954-6111(98)90006-3[Crossref]
  • [11] Allen J.N., Eosinophilic Lung Diseases, PCCU, 2004, 18, 14 lesson. www.chest.net.
  • [12] Umeki S., Soejima R., Acute and chronic eosinophilic pneumonia: clinical evaluation and the criteria, Inter. Med., 1992, 31, 847–56. http://dx.doi.org/10.2169/internalmedicine.31.847[Crossref]
  • [13] Hayakawa H., Sato A., Toyoshima M., Imokawa S., Taniguchi M., A clinical study of idiopathic eosinophilic pneumonia, Chest, 1994, 105, 1462–6 http://dx.doi.org/10.1378/chest.105.5.1462[Crossref]
  • [14] Danila E., Rare case of eosinophilic pneumonia, Vaiku pulmonologija ir alergologija, 1999, 2, 474–8 (in Lithuanian)
  • [15] Inoue K., Inoue Y., Arai T., Nawa Y., Kashiwa Y., Yamamoto S., et al., Chronic eosinophilic pneumonia due to visceral larva migrants, Inter. Med., 2002, 41, 478–82 http://dx.doi.org/10.2169/internalmedicine.41.478[Crossref]
  • [16] Xie L.X., Mo G.X., Chen L.A., Liu Y.N., Chronic eosinophilic pneumonia with mucous plugs: case report, Chin. Med. J. 2006, 119, 262–4
  • [17] Mitra S., Kundu S., Asthma, tuberculosis or eosinophilic pneumonia?, Lung India, 2007, 24, 94–6
  • [18] Gallipoli P., Leach M., A case of chronic eosinophilic pneumonia, J. R. Coll. Physicians Edinb., 2007, 37, 207–9
  • [19] Marchand E., Etienne-Mastroianni B., Chanez P., Lauque D., Leclerc P., Cordier J-F., Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?, Eur. Respir. J., 2003, 22, 8–13 http://dx.doi.org/10.1183/09031936.03.00085603[Crossref]
  • [20] Danila E., Zurauskas E., Loskutoviene G., Zablockis R., Nargela R., Birzietyte V., et al., Significance of bronchoscopic lung biopsy in clinical practice, Adv. Med. Sci., 2008, 53, 11–6 http://dx.doi.org/10.2478/v10039-008-0011-2[Crossref]
  • [21] Danila E., Jurgauskiene L., Malickaite R., BAL fluid cells and pulmonary function in different radiographic stages of newly diagnosed sarcoidosis, Adv. Med. Sci., 2008, 53, 228–33 http://dx.doi.org/10.2478/v10039-008-0014-z[Crossref]
  • [22] Danila E., Zurauskas E., Diagnostic value of epithelioid cell granulomas in bronchoscopic biopsies, Inter. Med., 2008, 47, 2121–6. http://dx.doi.org/10.2169/internalmedicine.47.1452[Crossref]
  • [23] Danila E., Jurgauskiene L., Norkuniene J., Malickaite R., BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity, Ups. J. Med. Sci., 2009, 114, 26–31. http://dx.doi.org/10.1080/03009730802579729[Crossref]
  • [24] Danila E., Norkuniene J., Jurgauskiene L., Malickaite R., Diagnostic role of BAL fluid CD4/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis, Clin. Respir. J., 2009, (in press), DOI: 10.1111/j.1752-699X.2008.00125.x.
  • [25] Marchand E., Cordier J.F., Idiopathic chronic eosinophilic pneumonia, Orphanet J. Rare Dis., 2006, 1, 11, http://www.OJRD.com/content/1/1/11 http://dx.doi.org/10.1186/1750-1172-1-11
  • [26] Bartlett J.G., Mundy L.M., Community-acquired pneumonia, N. Engl. J. Med., 1995, 333, 1618–24 http://dx.doi.org/10.1056/NEJM199512143332408[Crossref]
  • [27] Kradin R.L, Mark E.J., Case 32-1998. N. Engl. J. Med., 1998, 339, 1228–36 http://dx.doi.org/10.1056/NEJM199810223391708[Crossref]
  • [28] Arakawa H., Kurihara Y., Niimi H., Nakajima Y., Johkoh T., Nakamura H., Bronchiolitis obliterans with organizing pneumonia versus chronic eosinophilic pneumonia: high-resolution CT. Findings in 81 patients, A. J. R., 2001, 176, 1053–8
  • [29] Cordier J-F., Cryptogenic organizing pneumonia, Eur. Respir. J., 2006, 28, 422–46 http://dx.doi.org/10.1183/09031936.06.00013505[Crossref]
  • [30] Durieu J., Wallaert B., Tonnel A.B., Long-term follow-up of pulmonary function in chronic eosinophilic pneumonia, Eur. Respir. J., 1997, 10, 286–91 http://dx.doi.org/10.1183/09031936.97.10020286[Crossref]
  • [31] Wubbel C., Fulmer D., Sherman J., Chronic eosinophilic pneumonia: A case report and national survey, Chest, 2003, 123, 1763–6 http://dx.doi.org/10.1378/chest.123.5.1763[Crossref]
  • [32] Philit F., Etienne-Mastroïanni B., Parrot A., Guerin C., Robert D., Philit F., Idiopathic acute eosinophilic pneumonia: a study of 22 patients, Am. J. Respir. Crit. Care Med., 2002, 166, 1235–9 http://dx.doi.org/10.1164/rccm.2112056[Crossref]
  • [33] Hoare Z., Lim W.S., Pneumonia: update on diagnosis and management, B. M. J., 2006, 332, 1077–9 http://dx.doi.org/10.1136/bmj.332.7549.1077[Crossref]
  • [34] Sveinsson O.A., Isaksson H.J., Gudmundsson G., Chronic eosinophilic pneumonia in Iceland: clinical features, epidemiology and review, Laeknabladid, 2007, 93, 109–14, (in Icelandic)
  • [35] Almirall J., Bolíbar I., Toran P., Pera G., Boquet X., Balanzo X., et al., Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia, Chest, 2004, 125, 1335–42 http://dx.doi.org/10.1378/chest.125.4.1335[Crossref]
  • [36] Meer V., Neven A.K., Broek P.J., Assendelft W.J.J., Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review, B. M. J., 2005, 331, 1–6 http://dx.doi.org/10.1136/bmj.331.7507.1[Crossref]
  • [37] Jeong Y.J., Kim K-I., Seo I.J., Lee C.H., Lee K.N., Kim K.N., et al., Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview, RadioGraphics, 2007, 27, 617–37 http://dx.doi.org/10.1148/rg.273065051[Crossref]
  • [38] Johkoh T., Muller N.L., Akira M., Ichikado K., Suga M., Ando M., et al., Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients, Radiology, 2000, 216, 773–80
  • [39] Samman Y.S., Wali S.O., Abdelaal M.A., Gangi M.T., Krayem A.B., Chronic eosinophilic pneumonia presenting with recurrent massive bilateral pleural effusion: case report, Chest, 2001, 119, 968–70 http://dx.doi.org/10.1378/chest.119.3.968[Crossref]
  • [40] Mayo J.R., Muller N.L., Road J., Sisler J., Lillington G., Chronic eosinophilic pneumonia: CT findings in six cases, A. J. R., 1989, 153, 727–30
  • [41] Franquet T., Imaging of pneumonia: trends and algorithms, Eur. Respir. J., 2001, 18, 196–208 http://dx.doi.org/10.1183/09031936.01.00213501[Crossref]
  • [42] Woodhead M., Blasi F., Ewig S., Huchon G., Leven M., Ortqvist A., et al., Guidelines for the management of adult lower respiratory tract infections, Eur. Respir. J., 2005, 26, 1138–80 http://dx.doi.org/10.1183/09031936.05.00055705[Crossref]
  • [43] Lazor R., Vandevenne A., Pelletier A., Leclerc P., Court-Fortune I., Cordier J-F., Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients, Am. J. Respir. Crit. Care Med., 2000, 162, 571–7
  • [44] Laufs U., Schneider C., Wassermann K., Erdmann E., Chronic eosinophilic pneumonia with atypical radiographic presentation, Respiration, 1998, 65, 323–6 http://dx.doi.org/10.1159/000029287[Crossref]
  • [45] Azuma M., Nakamura Y., Sano T., Okano Y., Sone S., Adhesion molecule expression on eosinophils in idiopathic eosinophilic pneumonia, Eur. Respir. J., 1996, 9, 2494–500 http://dx.doi.org/10.1183/09031936.96.09122494[Crossref]
  • [46] Shijubo N., Fujishima T., Morita S., Nakata H., Satoh M., Uno E., et al. Idiopathic chronic eosinophilic pneumonia associated with noncaseating epithelioid granulomas, Eur. Respir. J., 1995, 8, 327–30 http://dx.doi.org/10.1183/09031936.95.08020327[Crossref]
  • [47] Ashitani J., Matsumoto N., Nakazato M., Elevated levels of antimicrobial peptides in bronchoalveolar lavage fluid in patients with chronic eosinophilic pneumonia, Respiration, 2007, 74, 69–75 http://dx.doi.org/10.1159/000090199[Crossref]
  • [48] Saita N., Yamanaka T., Kohrogi H., Ando M., Hirashima M., Apoptotic response of eosinophils in chronic eosinophilic pneumonia, Eur. Respir. J. 2001, 17, 190–4 http://dx.doi.org/10.1183/09031936.01.17201900[Crossref]
  • [49] Shijubo N., Shigehara K., Hirasawa M., Inuzuka M., Abe S., Eosinophilic cationic protein in chronic eosinophilic pneumonia and eosinophilic granuloma, Chest, 1994, 106, 1481–6 http://dx.doi.org/10.1378/chest.106.5.1481[Crossref]
  • [50] Giembycz M.A., Lindsay M.A., Pharmacology of the eosinophil, Pharm. Rev., 1999, 51, 213–39
  • [51] Yoshida K., Shijubo N., Koba H., Mori Y., Satoh M., Morikawa T., et al. Chronic eosinophilic pneumonia progressing to lung fibrosis, Eur. Respir. J., 1994, 7, 1541–4 http://dx.doi.org/10.1183/09031936.94.07081541[Crossref]
  • [52] Solans R., Bosch J.A., Perez-Bocanegra C., Selva A., Huguet P., Alijotas J., et al., Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients, Rheumatol., 2001, 40, 763–71 http://dx.doi.org/10.1093/rheumatology/40.7.763[Crossref]
Document Type
Publication order reference
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_s11536-009-0082-x
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.